Steven Nathan on Big Pharma: Aspen and Ascendis

Loading player...
10X founder Steven Nathan shares his pearls of wisdom on interesting developments taking place across local and international markets. Since his departure at 10X at the beginning of the year, Nathan has been on ‘garden leave’, which is a restraint of trade prohibiting him from working in the asset management industry for two years. Despite calling his time off “refreshing”, Nathan says it’s important to not lose focus and hence has been keeping up to date with all the market trends in 2021. Local talking points include Northam Platinum’s R17bn deal with Royal Bafokeng Platinum; representative of the Ascendis Activist Investors (Harry Smit) being appointed to the board of directors; and Mark Sardi departing the debt-laden pharma business for South Africa’s pharma leader, Aspen. Learn more about your ad choices. Visit megaphone.fm/adchoices
10 Nov 2021 8AM English South Africa Investing · Business News

Other recent episodes

The NdB Sunday Show | What Cyril knew before the Mkhwanazi presser…

In this edition of the NdB Sunday Show, Chris Steyn and independent intelligence analyst Jasmine Opperman talk about testimony at the Madlanga Commission of Inquiry that - six days before whistleblowing General Nhlanhla Mkhwanazi called his bombshell press conference - President Cyril Ramaphosa had a verbal intelligence briefing in which…
15 Nov 7AM 34 min

BN Edge | Piet le Roux: ICASA, Starlink and the true cost of BEE

To sell internet access in South Africa, you first have to show ICASA the race of your shareholders. Sakeliga has now taken the regulator to the Pretoria High Court, but, oddly, not to scrap the 30% black-ownership rule. Chief executive Piet le Roux told Alec Hogg why he chose the…
13 Nov 6AM 28 min